hrs-5635
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2023 (NCT05808374)
Timeline
Indications
Studied for
Mechanism of action
- Hepatitis B virusINHIBITOR
Hepatitis B virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06425341 | Phase 2 | Jun 14, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT05808374 | Phase 1 | Apr 30, 2023 | Jiangsu ShengDiYa Medicine Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu ShengDiYa Medicine Co., Ltd. | Government | 2 | 2 | 2 | 2023 |
1 organizations
Page 1 / 1